Health Condition 1: -
Conditions
Interventions
Intervention1: Ketofol( combination of Ketamine and Propofol in the ratio 1:5): Ketofol infusion ( 1 ml of study drug contains 8.33 mg of Propofol and 1.67 mg of Ketamine) used as maintenance agent fo
Sponsors
Department of anesthesia and intensive care PGIMER Chandigarh
Eligibility
Inclusion criteria
Inclusion criteria: ASA grade I/ IIE, with moderate to severe traumatic brain injury planned for decompressive craniectomy
Exclusion criteria
Exclusion criteria: patients with known psychiatric or neurodegenerative disease extradural hematomas pregnant females allergy to any of the study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| monitoring cerebral oxygenation by jugular venous oxygen saturation(SJVO2)Timepoint: baseline, at 1 hour and 2 hours of drug infusion, at 6 hours after end of drug infusion | — |
Secondary
| Measure | Time frame |
|---|---|
| Glasgow Outcome scale Extended(GOSE)Timepoint: at 1 and 3 months;hemodynamic parametersTimepoint: intraoperative and postoperative;Modified Rankins scale( MRS)Timepoint: at discharge;optic nerve sheath diameter (ONSD)Timepoint: Preoperative and postoperative;quality of brain relaxationTimepoint: intraoperative;S100B levelsTimepoint: preoperative , postoperative and 48 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Nidhi B Panda
PGIMER, CHANDIGARH
Outcome results
None listed